Guj. Inject (Kerala)
Ticker > Company >

Guj. Inject (Kerala) share price

Gujarat Inject (Kerala) Ltd.

BSE: 524238 SECTOR: Pharmaceuticals & Drugs  4155   5   0

24.48
0 0
BSE: 20 Dec 04:01 PM

Price Summary

Today's High

₹ 24.48

Today's Low

₹ 24.48

52 Week High

₹ 24.48

52 Week Low

₹ 8.74

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 35.86 Cr.

Enterprise Value

₹ 32.94 Cr.

No. of Shares

1.46 Cr.

P/E

46.33

P/B

3.68

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  6.65

CASH

₹ 2.92 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  0.53

Sales Growth

3231.11%

ROE

3.44 %

ROCE

2.54%

Profit Growth

101.63 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3231.11%
3 Year694.3%
5 Year∞%

Profit Growth

1 Year101.63%
3 Year40.72%
5 Year78.41%

ROE%

1 Year3.44%
3 Year1.15%
5 Year0.69%

ROCE %

1 Year2.54%
3 Year0.85%
5 Year0.51%

Debt/Equity

0

Price to Cash Flow

-5.95

Interest Cover Ratio

237.7054

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Mar 2024 0.00 0.00
Dec 2023 0.00 0.00
Sep 2023 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 694.295085793102% for the Past 3 years.
  • The company has significantly decreased its debt by 0.6076555 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -14.6229 days.
  • Company has a healthy liquidity position with current ratio of 40.772.

 Limitations

  • Company has a poor ROE of 1.14583333333333% over the past 3 years.
  • Company has a poor ROCE of 0.847466666666667% over the past 3 years
  • Company has negative cash flow from operations of -6.0276431.
  • The company has a low EBITDA margin of -279.731559515765% over the past 5 years.
  • The company is trading at a high PE of 46.33.
  • The company is trading at a high EV/EBITDA of 38.5197.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 0 0.22 5.42 3.05 8.61
Total Expenditure 0.01 0.25 5.37 2.88 8.07
Operating Profit -0.01 -0.03 0.04 0.16 0.54
Other Income 0.02 0.04 0 0 0.17
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.02 0.01 0.05 0.16 0.71
Tax 0 0 0.01 0.04 0.1
Profit After Tax 0.01 0 0.04 0.12 0.61
Adjusted EPS (Rs) 0.02 0.01 0.03 0.08 0.42

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0.01 0.02 0.17 5.79
Total Expenditure 0.01 0.12 0.07 0.55 5.74
Operating Profit -0.01 -0.11 -0.05 -0.38 0.04
Other Income 0.01 0.01 0.05 0.43 0.06
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0 -0.11 0 0.06 0.11
Tax 0 0 0 0.01 0.02
Net Profit 0 -0.11 0 0.04 0.08
Adjusted EPS (Rs.) 0 -0.22 0 0.08 0.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 4.88 4.88 4.88 4.88 11.29
Total Reserves -5.66 -5.77 -5.76 -5.72 -2.75
Borrowings 0.31 0.42 0.42 0.42 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 0.48 0.48 0.53 0.73 0.14
Total Liabilities 0.01 0.02 0.06 0.3 8.69
Assets
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0.04 0.23 2.98
Other N/C Assets 0 0 0 0 0
Current Assets 0.01 0.01 0.02 0.07 5.71
Total Assets 0.01 0.02 0.06 0.3 8.69
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0 -0.11 0 0.06 0.11
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities 0 0 0 0.01 -6.11
Tax Paid 0 0 0 -0.01 -0.02
Operating Cash Flow 0 -0.11 0 0.05 -6.03
Investing Cash Flow 0 0 0 0 0
Financing Cash Flow 0 0.1 0 0 8.88
Net Cash Flow 0 0 0 0.05 2.86

Corporate Actions

Investors Details

PARTICULARS Dec 2018% Mar 2019% Jun 2019% Sep 2019% Dec 2019%
promoters 24.30 24.30 24.30 24.30 24.30
murli nair 3.37 3.37 3.37 3.37 3.37
neha jain 3.27 3.27 3.27 3.27 3.27
niranjan jain 1.84 1.84 1.84 1.84 1.84
parikshit mahatma 3.37 3.37 3.37 3.37 3.37
rajeev mahatma 3.37 3.37 3.37 3.37 3.37
reena mahatma 3.62 3.62 3.62 3.62 3.62
sangeetaben jain 3.62 3.62 3.62 3.62 3.62
sonal mahatma 1.84 1.84 1.84 1.84 1.84
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 100.00 100.00 100.00 100.00 100.00
bhupendra j rathod (huf) - - 4.27 4.10 4.10
gautam keshavlal chauhan ... - - - 1.54 1.54
jagatsing nathusingh rath... - - - 4.10 4.10
jagrutbhai kesaribhai meh... - - 7.12 6.83 6.83
jaydeepa bhupendra rathod... - - 4.27 4.10 4.10
jignesh shivlal makasana - - 12.46 11.95 11.95
kamlaba j rathod - - 3.86 3.70 3.70
meenaben surendrakumar sh... - - 3.56 3.41 3.41
parikshit mahatma 3.31 3.31 1.15 1.11 1.11
patel mital shreyasbhai - - 1.78 1.71 1.71
pradip narottambhai vegad... - - 3.08 2.95 2.95
rajesh shantilal sanghvi - - 7.12 6.83 6.83
shah surendra nemchand - - 3.56 3.41 3.41
shivlal kuberbhai patel - - 12.46 11.95 11.95
gautam chauhan 1.31 1.31 0.46 0.44 -
gautam keshavlal chauhan ... - - 1.60 - -
govind rathore 1.31 1.31 - - -
mit jimit sanghvi 1.31 1.31 - - -
murali nair 1.84 1.84 - - -
neha jain 1.84 1.84 - - -
nishant jain 1.31 1.31 - - -
piyush jain 1.31 1.31 - - -
pradeep vegda 1.31 1.31 - - -
rajeev mahatma 1.84 1.84 - - -
sangitaben jain 1.84 1.84 - - -
sonal jain 1.84 1.84 - - -
vasudev bachani 1.31 1.31 - - -
virendrasingh shekhawat 1.31 1.31 - - -
vivek kanda - 1.22 - - -
kumar gaurav gupta 6.16 - - - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Gujarat Inject (Kerala) informs about outcome of board meeting 22 Oct, 5:33 PM Guj. Inject (Kerala) - Quaterly Results 22 Oct, 4:49 PM Guj. Inject (Kerala) - Quaterly Results 22 Oct, 4:49 PM Guj. Inject (Kerala) - Quaterly Results 22 Oct, 4:49 PM Guj. Inject (Kerala) - Quaterly Results 10 Aug, 3:53 PM Guj. Inject (Kerala) - Quaterly Results 10 Aug, 3:53 PM Guj. Inject (Kerala) - Quaterly Results 10 Aug, 3:53 PM Guj. Inject (Kerala) - Quaterly Results 9 May, 5:15 PM Guj. Inject (Kerala) - Quaterly Results 9 May, 5:15 PM Guj. Inject (Kerala) - Quaterly Results 9 May, 5:15 PM Guj. Inject (Kerala) - Quaterly Results 13 Feb, 5:14 PM Guj. Inject (Kerala) - Quaterly Results 13 Feb, 5:14 PM Gujarat Inject (Kerala) informs about confirmation certificate 16 Jan, 5:18 PM Gujarat Inject (Kerala) submits corrigendum to EGM notice 8 Jan, 5:13 PM Guj. Inject (Kerala) - Quaterly Results 6 Nov, 6:22 PM Guj. Inject (Kerala) - Quaterly Results 6 Nov, 6:22 PM Guj. Inject (Kerala) - Quaterly Results 14 Aug, 4:27 PM Guj. Inject (Kerala) - Quaterly Results 22 May, 5:49 PM Guj. Inject (Kerala) - Quaterly Results 22 May, 5:49 PM Guj. Inject (Kerala) - Quaterly Results 10 Feb, 5:11 PM Guj. Inject (Kerala) - Quaterly Results 10 Feb, 5:11 PM Gujarat Inject (Kerala) informs about outcome of board meeting 31 Oct, 5:12 PM Gujarat Inject Kerala informs about newspaper advertisement 17 Oct, 12:53 PM Gujarat Inject (Kerala) informs about compliances-certificate 19 Jul, 12:55 PM Gujarat Inject Kerala informs about board meeting 24 Jun, 5:04 PM

Guj. Inject (Kerala) Stock Price Analysis and Quick Research Report. Is Guj. Inject (Kerala) an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Guj. Inject (Kerala) and its performance over the period of time. Guj. Inject (Kerala) stock price today is Rs 24.48.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Guj. Inject (Kerala) cash from the operating activity was Rs -6.0276431 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Guj. Inject (Kerala) has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Guj. Inject (Kerala) , the EPS growth was -12.7381 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Guj. Inject (Kerala) has OPM of 0.775083017214066 % which is a bad sign for profitability.
     
  • ROE: Guj. Inject (Kerala) have a poor ROE of 3.4375 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Guj. Inject (Kerala) is Rs 24.48. One can use valuation calculators of ticker to know if Guj. Inject (Kerala) share price is undervalued or overvalued.
Last Updated on:
Brief about Guj. Inject (Kerala)
X